---
layout: default
title: 780Mg Metformin Base
parent: Low Evidence (L5)
nav_order: 15
evidence_level: L5
indication_count: 0
---

# 780Mg Metformin Base
{: .fs-9 }

Evidence Level: **L5** | Predicted Indications: **0** 
{: .fs-6 .fw-300 }

---

## Table of Contents
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## Pharmacist Assessment Report

</div>

# 780MG METFORMIN BASE): Insufficient Data Quality to Complete Drug Repurposing Assessment

> ⚠️ **Notice**: This report cannot be completed in standard format due to severe data quality issues with the input data. The following is an analysis of data gaps and recommended actions.

---

## One-Sentence Summary

The drug field (INN) in this Evidence Pack contains a non-standard string `"780MG METFORMIN BASE)"`, which appears to result from a parsing error where dosage specifications were inadvertently mixed into the drug name field, rather than representing a correct international nonproprietary name.
Due to failed drug identification, the system was unable to retrieve any TxGNN predicted indications, Singapore market availability data, or safety data. **At present, drug repurposing assessment cannot be executed**.

---

## Quick Overview

| Item | Content |
|------|---------|
| Input Drug Name (Raw) | `780MG METFORMIN BASE)` ← suspected parsing error |
| Presumed Correct Drug | Metformin (Metformin HCl, biguanide antidiabetic) |
| Predicted New Indications | None (predicted_indications array is empty) |
| TxGNN Prediction Score | No data |
| Evidence Level | L5 (model prediction data missing) |
| Singapore Market Status | Not marketed (0 approvals) |
| License Count | 0 |
| Recommended Decision | **Hold** |

---

## Why is This Prediction Reasonable?

Due to the empty `predicted_indications` array, mechanistic relevance analysis cannot be performed in this section.

Should the drug be confirmed as **Metformin**, its mechanism of action (AMPK activation, hepatic gluconeogenesis inhibition) possesses a rich research foundation in the drug repurposing field (cancer, PCOS, NAFLD, neurodegenerative disease, etc.), and **would merit evaluation**. However, until the drug identification issue is resolved, no prediction interpretation should be undertaken.

---

## Clinical Trial Evidence

No relevant clinical trial data are currently available (predicted_indications is empty, precluding queries).

---

## Literature Evidence

No relevant literature data are currently available (predicted_indications is empty, precluding queries).

---

## Singapore Market Information

The present query retrieved no Singapore approval records (total_licenses: 0).

Should drug identification be confirmed as Metformin, re-querying is warranted—Metformin is widely marketed in Singapore and would be expected to have multiple HSA approval records.

---

## Safety Considerations

Please consult product labeling warnings and contraindications. Safety data queries failed to return results, possibly due to failed drug identification.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The drug identification field (INN) contains a malformed string, resulting in complete failure of DrugBank mapping, TxGNN prediction, Singapore market availability query, and safety assessment. Without data correction, this case presents no evaluable prediction evidence.

**To proceed, the following is needed:**

1. **Resolve drug identification issue (Blocking)**
   - Confirm correct INN: if Metformin, input should be `metformin` (lowercase, no parentheses, no dosage specifications)
   - Re-trigger Evidence Pack generation workflow

2. **Supplement DrugBank ID (High)**
   - Metformin DrugBank ID is `DB00331`
   - Supplementation enables retrieval of complete MOA, drug classification, and safety data

3. **Re-execute TxGNN prediction**
   - Upon confirmation of drug identification, regenerate `predicted_indications`

4. **Supplement Singapore HSA data (High)**
   - Metformin should have market records in Singapore; re-query to confirm

5. **Supplement product labeling safety data (Blocking)**
   - Per DG001 remediation measures: download product labeling PDF for parsing of warnings and contraindications

## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

